x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

science medicine

All Episodes

01:01:12

Bispecific Antibodies in the Management of Lymphoma —...

Hematologic Oncology Update ·

2026/01/21

Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.CME information and select publications here.

en

01:01:06

Relapsed/Refractory Multiple Myeloma — ASH 2025 Review

Hematologic Oncology Update ·

2026/01/16

Dr Sagar Lonial from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr María-Victoria Mateos from the University Hospital of Salamanca in Salamanca, Spain, discuss cases of relapsed/refractory multiple myeloma and recentresearch findings from the 2025 ASH Annual Meeting. CME information and select publications here.

en

01:56:55

Follicular Lymphoma and Diffuse Large B-Cell Lymphoma...

Hematologic Oncology Update ·

2026/01/13

Dr Nancy L Bartlett from the Washington University School of Medicine, Dr John P Leonard from the Perlmutter Cancer Center, Dr Matthew Matasar from Rutgers Cancer Institute, Dr Loretta J Nastoupil from Southwest Oncology and Prof Pier Luigi Zinzani from the University of Bologna in Italy discuss recent updates on available and novel treatment strategies for follicular lymphoma and diffuse large B-cell lymphoma. CME information and select publications here.

en

01:57:30

Myelofibrosis and Systemic Mastocytosis — Proceedings...

Hematologic Oncology Update ·

2026/01/09

Prof Claire Harrison from Guy’s and St Thomas’ NHS Foundation Trust in London, Dr Andrew T Kuykendall from Moffitt Cancer Center, Dr Stephen T Oh from the Washington University School of Medicine, Dr Jeanne Palmer from the Mayo Clinic School of Medicine and Dr Raajit K Rampal from Memorial Sloan Kettering Cancer Center discuss recent updates on available and novel treatment strategies for myelofibrosis and systemic mastocytosis.CME information and select publications here.

en

01:55:47

Chronic Lymphocytic Leukemia — Proceedings from a...

Hematologic Oncology Update ·

2026/01/07

Dr Matthew S Davids from Dana-Farber Cancer Institute, Dr Bita Fakhri from Stanford University School of Medicine, Prof Constantine Tam from Alfred Health in Melbourne, Australia, and Dr Jennifer Woyach from The Ohio State University Comprehensive Cancer Center review the treatment landscape for patients with chronic lymphocytic leukemia and discuss current research immediately before the 67th ASH Annual Meeting.CME information and select publications here.

en

01:57:33

Acute Myeloid Leukemia — Proceedings from a Symposium...

Hematologic Oncology Update ·

2026/01/03

Dr Harry Paul Erba from the Duke Cancer Institute, Dr Amir Fathi from Massachusetts General Hospital, Dr Tara L Lin from The University of Kansas Medical Center, Dr Alexander Perl from the University of Pennsylvania’s Abramson Cancer Center and Dr Eytan M Stein from Memorial Sloan Kettering Cancer Center discuss recent data surrounding the management of AML and their perspectives on clinical application.CME information and select publications here.

en

51:19

Chronic Lymphocytic Leukemia — Proceedings from a...

Hematologic Oncology Update ·

2025/12/12

Dr Kerry A Rogers from The Ohio State University in Columbus summarizes the treatment landscape and reviews relevant clinical datasets for patients with chronic lymphocytic leukemia.CME information and select publications here.

en

58:30

CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer...

Hematologic Oncology Update ·

2025/12/11

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma.CME information and select publications here.

en

52:03

Toxicities Associated with CAR T-Cell Therapy — An...

Hematologic Oncology Update ·

2025/12/04

Dr Matthew Lunning from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on the management of toxicities associated with CAR T-cell therapy.CME information and select publications here.

en

59:42

Patient Education Resource: Non-Hodgkin Lymphoma —...

Hematologic Oncology Update ·

2025/11/15

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma.Educational information and select publications here.

en

01:00:13

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma...

Hematologic Oncology Update ·

2025/11/13

Dr Matthew Lunning and Dr Sonali M Smith share their perspectives on the evolving therapeutic landscape for patients with diffuse large B-cell lymphoma and follicular lymphoma.CME information and select publications here.

en

54:59

Acute Myeloid Leukemia — An Interview with Dr Eunice...

Hematologic Oncology Update ·

2025/10/23

Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses recent datasets and their implications for the current and future management of acute myeloid leukemia.CME information and select publications here.

en

57:59

Non-Hodgkin Lymphoma — The Implications of Recent...

Hematologic Oncology Update ·

2025/10/18

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, review recent datasets and their significance for the management of various forms of non-Hodgkin lymphoma.CME information and select publications here.

en

59:34

Follicular Lymphoma — Proceedings from a Session Held...

Hematologic Oncology Update ·

2025/10/10

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma. CE information and select publications here.

en

58:47

Acute Myeloid Leukemia — An Interview with Dr Ghayas...

Hematologic Oncology Update ·

2025/10/09

Dr Ghayas Issa from The University of Texas MD Anderson Cancer Center in Houston discusses data guiding the use of menin inhibitors for patients with acute myeloid leukemia and select alterations.CME information and select publications here.

en

58:29

Relapsed/Refractory Multiple Myeloma — Proceedings...

Hematologic Oncology Update ·

2025/10/03

Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel treatment strategies for relapsed/refractory multiple myeloma. CE information and select publications here.

en

53:08

Oncology Nursing Update: Multiple Myeloma — An...

Hematologic Oncology Update ·

2025/09/19

Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma.NCPD information and select publications here.

en

54:23

Ocular Toxicities Associated with Antibody-Drug...

Hematologic Oncology Update ·

2025/09/16

Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management.CME information and select publications here.

en

57:47

Ocular Toxicities Associated with Antibody-Drug...

Hematologic Oncology Update ·

2025/09/15

Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated with antibody-drug conjugates and other cancer therapies.CME information and select publications here.

en

54:17

Oncology Nursing Update: Newly Diagnosed Multiple...

Hematologic Oncology Update ·

2025/09/06

Ms Charise Gleason from Emory Healthcare in Atlanta, Georgia, discusses the evolution of first-line therapy for patients with multiple myeloma.NCPD information and select publications here.

en

601 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter